摘要
目的:研究葛根汤颗粒对甲型H_(1)N_(1)流感病毒PR8株感染致小鼠病毒性肺炎模型的治疗及死亡保护作用。方法:采用甲型H1N1流感病毒(PR8株)滴鼻感染小鼠造成病毒性肺炎模型,观察小鼠的肺指数和肺指数抑制率,肺内细支气管及肺组织苏木精-伊红(HE)染色病理切片镜下病变观察及等级评分;同时采用流感病毒PR8毒株滴鼻感染小鼠造成死亡保护模型,观察小鼠感染后2周内的死亡情况,计算小鼠的死亡率、死亡保护率、平均存活天数和生命延长率。结果:葛根汤颗粒高、中剂量组可显著降低模型组小鼠肺指数(P<0.01);葛根汤颗粒高、中剂量组与模型组比较可显著减轻支气管炎症反应渗出状况,红肿相对消退,并且缓解病毒感染所致肺泡、肺间质渗出炎症反应及红细胞渗出情况(P<0.01,P<0.05);模型组小鼠死亡率90%,平均存活天数9.95 d,葛根汤颗粒3个剂量组与模型组比较可显著降低小鼠死亡率,延长小鼠平均存活天数,提高生命延长率(P<0.01,P<0.05)。结论:本研究发现葛根汤颗粒可显著降低病毒性肺炎模型小鼠的肺指数,并显著减轻病毒感染所致的小鼠肺内细支气管及肺局部炎症反应损伤,对模型小鼠的肺部炎症反应有明显的治疗作用;同时可显著降低模型小鼠死亡率,延长平均存活天数,提高生命延长率,对感染小鼠有死亡保护作用。
Objective:To study the therapeutic and death protective effects of Gegentang Granules on the mouse model of viral pneumonia caused by infection with influenza A(H_(1)N_(1))virus PR8 strain.Methods:The mouse model of viral pneumonia was established by nasal dripping with influenza A H_(1)N_(1) virus(PR8 strain).The lung index and lung index inhibition rate were recorded,and the pathological changes of the bronchus and lung tissue were observed and graded by hematoxylin-eosin staining.At the same time,we established a mouse model of influenza virus PR8 strain infection by nasal dripping to observe the death of mice within 2 weeks after infection,and recorded the mortality rate,death protection rate,average survival days,and life extension rate.Results:Medium-and high-dose Gegentang Granules reduced the lung index(P<0.01)and alleviated bronchial inflammation and exudation,redness and swelling,alveolar and pulmonary interstitial inflammation,and erythrocyte extravasation caused by viral infection(P<0.01,P<0.05)compared with the model group.The mice in the model group showed a mortality rate of 90% and the average survival of 9.95 days.Compared with the model group,the three doses of Gegentang Granules reduced the mortality rate of mice,prolonged the average survival days,and improved the life extension rate of mice(P<0.01,P<0.05).Conclusion:Gegentang Granules can significantly reduce the lung index and alleviate the bronchial and local pulmonary inflammation caused by viral infection,demonstrating an obvious therapeutic effect on the pulmonary inflammation of the model mice.Moreover,it can significantly reduce the mortality,prolong the average survival days,and improve the life extension rate,protecting the infected mice from death.
作者
赵荣华
孙静
包蕾
耿子涵
张敬升
庞博
陶夏莉
刘进娜
郭姗姗
徐英莉
李舒冉
周利润
曹姗
陈梦苹
张宇
鲍岩岩
王道涵
崔晓兰
ZHAO Ronghua;SUN Jing;BAO Lei;GENG Zihan;ZHANG Jingsheng;PANG Bo;TAO Xiali;LIU Jinna;GUO Shanshan;XU Yingli;LI Shuran;ZHOU Lirun;CAO Shan;CHEN Mengping;ZHANG Yu;BAO Yanyan;WANG Daohan;CUI Xiaolan(Biosecurity Laboratory,Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Beijing Reno Technology Co.,Ltd,Beijing 100095,China;College of Integrated Chinese and Western Medicine,Hebei Medical University,Shijiazhuang 050017,China;Department of Pediatrics,Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China)
出处
《世界中医药》
CAS
2023年第10期1385-1390,共6页
World Chinese Medicine
基金
国家重点研发计划项目(2020YFE0205100)——中国-奥地利中医药防治重大感染性疾病“一带一路”联合实验室建设与联合研究
中国中医科学院科技创新工程项目(CI2021A04606)——针对疫病早期防治的中药筛选及药效评价应急性平台建设
河北省中医药管理局科研计划项目(2022131)——基于网络药理学探讨补中益气汤治疗气虚发热证的分子机制。